Shares of Moderna tumbled in early trading Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year. Moderna said it expects 2025 revenue to range between $1.5 ...
WASHINGTON, Jan 19 — US health officials announced on Friday that they were awarding US$590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback